The effect of Sevoflurane on microvascular endothelium function and outcome of patients undergoing thoracic surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022773

Enrollment

Unknown

Registered

2019-04-25

Start date

2019-05-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Tumor

Interventions

1:Propofol + Sevoflurane group

2:Propofol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing radical endoscopic esophageal cancer radical surgery, gender is not limited, aged less than 80 years , ASA grade I-III grade; cardiac function grade I-II grade.

Exclusion criteria

Exclusion criteria: Exclusion of preoperative pulmonary function tests for patients with moderate to severe airway dysfunction, or ventilatory dysfunction.

Design outcomes

Primary

Measure	Time frame
Angiopoietin-2;	—

Countries

China

Contacts

Public ContactFan Jiang

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University

jiangfanmz@163.com+86 18355990711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026